Boston Scientific Acquires SVG Embolic Protection At Reduced Cost
This article was originally published in The Gray Sheet
Executive Summary
Rubicon Medical will forego a higher payment for its embolic filter technology than originally expected from Boston Scientific, opting instead for immediate cash flow to support commercialization